SPRC Latest Headlines

SciSparc Bolsters Agentic AI Push with Appointment of Technion Expert to Advisory Board

at www.tipranks.com (Wed, 26-Aug 4:59 PM)

SciSparc Highlights NeuroThera-Clearmind MDMA-PEA Patent Milestone Amid New FDA Psychedelic Guidance

at www.tipranks.com (Mon, 24-Aug 9:47 AM)

SciSparc’s Stake in NeuroThera Soars to C$30 Million After Financing: Majority Ownership Solidified

Market Chameleon (Tue, 18-Aug 8:34 AM)

SPRC Strengthens Patent Portfolio with Japanese Approval—Expanding Global Reach for Innovative Pain Therapies

Market Chameleon (Wed, 12-Aug 9:10 AM)

SciSparc's NeuroThera Launches Phase IIb Trial at Yale for Pioneering Tourette Syndrome Treatment

Market Chameleon (Wed, 5-Aug 9:00 AM)

SciSparc’s Quantum Platform Milestone Sets New Standard for Clinical Data Analytics

Market Chameleon (Fri, 31-Jul 9:18 AM)

SPRC Subsidiary NeuroThera Labs Validates Quantum Platform for Clinical Data on S&P 500 Infrastructure

Market Chameleon (Wed, 29-Jul 11:07 AM)

SciSparc’s NeuroThera Labs Validates Quantum Data Platform—A Leap Forward for Clinical Analytics

Market Chameleon (Wed, 29-Jul 9:08 AM)

SciSparc Sets Its Sights on Agentic AI and Cybersecurity with New Scientific Advisory Board

Market Chameleon (Mon, 27-Jul 9:20 AM)

SciSparc’s Subsidiary NeuroThera Acquires CliniQuantum, Expanding Quantum Clinical Trial Capabilities

Market Chameleon (Thu, 4-Jun 10:30 AM)

SciSparc’s Subsidiary Expands Quantum Pharma Ambitions With CliniQuantum Acquisition—All Eyes on Clinical Data Innovation

Market Chameleon (Thu, 4-Jun 7:54 AM)

SciSparc’s NeuroThera Gets Green Light for 54% CliniQuantum Acquisition—Regulatory Approval Sets Stage for Quantum-Powered Drug Trials

Market Chameleon (Thu, 28-May 9:52 AM)